TWI449514B - Measurement of arrhythmia - Google Patents
Measurement of arrhythmia Download PDFInfo
- Publication number
- TWI449514B TWI449514B TW098114098A TW98114098A TWI449514B TW I449514 B TWI449514 B TW I449514B TW 098114098 A TW098114098 A TW 098114098A TW 98114098 A TW98114098 A TW 98114098A TW I449514 B TWI449514 B TW I449514B
- Authority
- TW
- Taiwan
- Prior art keywords
- signal
- heart rate
- measuring device
- rate variability
- light
- Prior art date
Links
- 238000005259 measurement Methods 0.000 title claims description 59
- 206010003119 arrhythmia Diseases 0.000 title description 7
- 230000006793 arrhythmia Effects 0.000 title description 7
- 238000012545 processing Methods 0.000 claims description 47
- 230000033764 rhythmic process Effects 0.000 claims description 15
- 230000005236 sound signal Effects 0.000 claims description 13
- 238000010586 diagram Methods 0.000 claims description 12
- 239000004973 liquid crystal related substance Substances 0.000 claims description 12
- 210000003491 skin Anatomy 0.000 claims description 12
- 230000005540 biological transmission Effects 0.000 claims description 9
- 230000035790 physiological processes and functions Effects 0.000 claims description 8
- 238000003780 insertion Methods 0.000 claims description 6
- 230000037431 insertion Effects 0.000 claims description 6
- 206010029216 Nervousness Diseases 0.000 claims description 5
- 210000004207 dermis Anatomy 0.000 claims description 4
- 239000010409 thin film Substances 0.000 claims description 4
- 230000000747 cardiac effect Effects 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 2
- 230000003287 optical effect Effects 0.000 claims description 2
- 238000012546 transfer Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 description 11
- 238000013186 photoplethysmography Methods 0.000 description 7
- 210000001367 artery Anatomy 0.000 description 6
- 210000003403 autonomic nervous system Anatomy 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 206010049976 Impatience Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 239000011521 glass Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 230000001121 heart beat frequency Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000002889 sympathetic effect Effects 0.000 description 3
- 210000002820 sympathetic nervous system Anatomy 0.000 description 3
- 206010042434 Sudden death Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 210000000467 autonomic pathway Anatomy 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000002996 emotional effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 230000001734 parasympathetic effect Effects 0.000 description 2
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000001428 peripheral nervous system Anatomy 0.000 description 1
- 230000008288 physiological mechanism Effects 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000001671 psychotherapy Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
- A61B5/02416—Measuring pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
- A61B5/02427—Details of sensor
- A61B5/02433—Details of sensor for infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
- A61B5/02405—Determining heart rate variability
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
- A61B5/0245—Measuring pulse rate or heart rate by using sensing means generating electric signals, i.e. ECG signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
- A61B5/352—Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6814—Head
- A61B5/6815—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6814—Head
- A61B5/6815—Ear
- A61B5/6817—Ear canal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
- A61B5/02438—Measuring pulse rate or heart rate with portable devices, e.g. worn by the patient
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Otolaryngology (AREA)
- Physiology (AREA)
- Signal Processing (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Description
本發明係有關於一種量測裝置,特別是指一種心律變異度之量測裝置。The present invention relates to a measuring device, and more particularly to a measuring device for heart rate variability.
心率變異度(Heart Rate Variability,HRV)的心率是指心臟跳動的頻率,單位是BPM(Beat Per Minute),是由1981年Akselrod發表,其藉由非侵入的方式量測並紀錄心電訊號,在經過快速傅立葉轉換以求得心率變異特性的功率頻譜;而變異度則是每個心跳時間間格上的差距,亦即心臟跳動的頻率與心跳時間間格上的程度變化。心率變異度之特性功率頻譜可以對應出自主神經系統之生理作用機制。長時間HRV的高低變化可以反應一個人的自律神經是否失調,也可以反應出心臟功能的健康情形。Heart Rate Variability (HRV) heart rate refers to the frequency of heart beats, in BPM (Beat Per Minute), published by Akselrod in 1981, which measures and records ECG signals in a non-invasive manner. The fast power Fourier transform is used to obtain the power spectrum of the heart rate variability characteristic; and the variability is the difference in the lattice time between each heartbeat time, that is, the degree of the difference between the frequency of the heart beat and the heartbeat time. The characteristic power spectrum of heart rate variability can correspond to the physiological mechanism of the autonomic nervous system. The high and low changes of HRV for a long time can reflect whether a person's autonomic nerve is out of tune, and can also reflect the health of heart function.
自主神經系統屬於周邊神經系統的一部份,它控制身體內器官的功能,自主神經系統分為兩類:交感和副交感神經系統。交感神經系統在有壓力的時候其活動占優勢,所產生的效應讓身體預備在面對壓力反應時做出動作。它的效用是為身體消耗能量;而副交感系統則是在休息及靜養時其活動占優勢,所產生的效應會加速及調節諸如消化和生長的過程。為了讓身體能休息及靜養,它的活動可用來保存能量。The autonomic nervous system is part of the peripheral nervous system, which controls the function of organs in the body. The autonomic nervous system is divided into two categories: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system predominates its activity when stressed, and the resulting effects prepare the body to act in the face of stress responses. Its utility is to consume energy for the body; while the parasympathetic system prevails during rest and rest, and the effects that accelerate and regulate processes such as digestion and growth. In order to allow the body to rest and rest, its activities can be used to conserve energy.
目前評估自主神經系統活動最有效的方法就是心率變異度(HRV)之分析。HRV特性會由交感與副交感神經系統交互作用與調控產生變異,所以醫學上常藉由心率變異來研究自主神經系統的調節情形。因此由心率變異度的高低,即可得知一個人的自主神經是否失調,而心率變異度亦可反應心臟功能的健康,其低變異度代表著高心臟病危險性。因此藉由心率變異特性可作為多項疾病判斷或治療之徵兆,例如心律不整、糖尿病、憂鬱症等。The most effective method for assessing autonomic nervous system activity is the analysis of heart rate variability (HRV). The HRV characteristics are mutated by the interaction and regulation of the sympathetic and parasympathetic nervous systems. Therefore, the regulation of the autonomic nervous system is often studied by heart rate variability in medicine. Therefore, from the level of heart rate variability, it can be known whether a person's autonomic nerve is out of tune, and heart rate variability can also reflect the health of heart function, and its low variability represents a high risk of heart disease. Therefore, the heart rate variability can be used as a symptom of a plurality of disease judgments or treatments, such as arrhythmia, diabetes, depression, and the like.
「心律不整」是指心跳不正常,亦即心跳間隔長短不同,而心跳的頻率過快或過慢時也算是心律不整,例如心跳頻率比正常快的「頻脈」或是心跳頻率比正常慢的「徐脈」。除了某些心臟本身有疾病時會發生心律不整之情形外,因呼吸有所變動時亦會發生心律不整之情形;例如一個人深深吸氣時心跳會加快,而把氣吐出來時心跳就會慢下來,這是正常的生理現象。此外如運動時心跳會加快,而休息或睡覺時心跳則會變慢,另外如自主神經系統的興奮、咖啡或茶的刺激、發燒、緊張、壓力過大、疼痛、缺氧、藥物等等,都可能使心跳速率及節律有所改變。"Arrhythmia" means that the heartbeat is not normal, that is, the heartbeat interval is different. When the heartbeat frequency is too fast or too slow, it can be regarded as arrhythmia. For example, the heartbeat frequency is faster than normal, or the heartbeat frequency is slower than normal. "Xu Mai". In addition to some cases where the heart itself has a disease, arrhythmia may occur. When the breathing changes, arrhythmia may occur. For example, when a person inhales deeply, the heart beats faster, and when the gas is spit out, the heart beats. Slow down, this is a normal physiological phenomenon. In addition, the heart rate will increase when exercising, and the heartbeat will slow down during rest or sleep. In addition, the excitement of the autonomic nervous system, coffee or tea stimulation, fever, nervousness, stress, pain, hypoxia, drugs, etc. It may change the heart rate and rhythm.
心律不整時,從毫無症狀到有一些輕微症狀如:感覺心跳加快,或是感覺到不規則的心跳;當心律不整嚴重時,會引起病人休克、昏倒甚至猝死。不少猝死病患平時並無任何徵候,即使年輕人也可能發生。醫學界現在認為,除了藉由過去病例分析外,可藉由心率變異度之突然降低作為疾病的預測指標。尤其是經常忙碌的人,經由長期心率變異度的監控,若發現HRV偏低或逐漸降低,則應立刻休息,可減少猝死之機率。When the heart rhythm is not complete, from no symptoms to some mild symptoms such as: feeling a rapid heartbeat, or feeling an irregular heartbeat; when the heart rhythm is not serious, it may cause the patient to shock, faint or even drown. Many sudden death patients usually have no signs, even young people may occur. The medical community now believes that, in addition to past case analysis, sudden decline in heart rate variability can be used as a predictor of disease. Especially for people who are busy, after monitoring the long-term heart rate variability, if the HRV is found to be low or gradually reduced, it should be rested immediately, which can reduce the chance of sudden death.
HRV亦可作為糖尿病(Diabetes)之治療效果的判斷。糖尿病患初期,在血糖雖維持正常範圍內,但HRV已逐漸下降。而中期及末期的糖尿病患可能併發神經壞死症(Diabetic Neuropathy),此時交感及副交感之細小纖維開始壞死,病人會出現站立眩暈(低血壓)、心悸、盜汗、及肚瀉等自律神經失調症狀。經由長期量測HRV,會發現HRV偏離原有之基準線,治療效果也可依此判斷。HRV can also be used as a judgment for the therapeutic effect of Diabetes. In the early stage of diabetes, although the blood sugar remained within the normal range, the HRV has gradually decreased. In the middle and late stages of diabetes, Diabetic Neuropathy may be complicated. At this time, the sympathetic and parasympathetic fine fibers begin to necrosis, and patients may experience symptoms such as standing vertigo (hypotension), palpitations, night sweats, and diarrhea. . After long-term measurement of HRV, it will be found that HRV deviates from the original baseline, and the treatment effect can be judged accordingly.
另外,HRV亦可判斷憂鬱症(Depression)的發病。憂鬱症是一種醫學疾病,不僅僅是「情緒沮喪」而已。每年有上千萬的人患上這種疾病;婦女患有憂鬱症的可能性是男性的兩倍。患有其他疾病,比如心臟病、中風、癌症及糖尿病的患者病發憂鬱症的機率更高。而這些病患的HRV在量測上通常顯現活性偏低之情形。文獻顯示許多西醫處方藥可以改善憂鬱症狀。據估計,80%至90%的憂鬱症患者可以經專業的藥物療法和心理療法而痊癒。若長期利用HRV的量測來追蹤療效,則可更快使憂鬱症痊癒。In addition, HRV can also determine the onset of depression. Depression is a medical condition, not just "emotional depression." Tens of millions of people suffer from this disease every year; women are twice as likely to have depression as men. Patients with other diseases, such as heart disease, stroke, cancer and diabetes, are more likely to develop depression. The HRV of these patients usually shows a low activity in the measurement. The literature shows that many Western medicine prescription drugs can improve the symptoms of depression. It is estimated that 80% to 90% of people with depression can be cured by professional drug therapy and psychotherapy. If the HRV measurement is used for a long time to track the curative effect, the depression can be healed more quickly.
若要獲得HRV的資訊,不需要分析整個心電圖的細節,只要能取得心跳的間期,就能由心跳間期分析而得到。測量HRV是需要一段時間,約十分鐘以上,沒辦法在短時間內知道結果。量測的方法,首先需要找到心電訊號的心跳間期,然後經過重新取樣,把取樣後的資料經過快速傅立葉轉換,即可求得心律變異的功率頻譜,從心率變異的功率頻譜可以得到高頻(0.15-0.4Hz)和低頻(0.04-0.15Hz)的功率,由高低頻功率的變化可以當作自律神經活性的指標。To get the HRV information, you don't need to analyze the details of the entire ECG. As long as you can get the heartbeat interval, you can get it from the heartbeat interval analysis. Measuring HRV takes a while, about ten minutes or more, and there is no way to know the result in a short time. The measurement method first needs to find the heartbeat interval of the ECG signal, and then after re-sampling, the sampled data is subjected to fast Fourier transform to obtain the power spectrum of the heart rate variation, and the power spectrum from the heart rate variation can be obtained high. The frequency (0.15-0.4 Hz) and low frequency (0.04-0.15 Hz) power, as a function of high and low frequency power, can be used as an indicator of autonomic nervous activity.
然而在長時間的量測下,如果讓受測者的注意力一直集中在被量測這件事情上,可能會使他們感到緊張或者不耐煩,而無法獲得自然的生理資訊,然而在長時間的量測下,比較容易觀察出心臟是否有問題存在,如果是短時間的量測,再加上受測者的緊張或者不耐煩,有些疾病並無法觀察出來,例如:偶發性心律不整。However, under long-term measurement, if the subject's attention is always focused on the measurement, it may make them nervous or impatient, but they cannot obtain natural physiological information, but for a long time. Under the measurement, it is easier to observe whether there is a problem in the heart. If it is a short-term measurement, plus the tension or impatientness of the subject, some diseases cannot be observed, for example: sporadic arrhythmia.
因此本發明提供一種心律變異度之量測裝置,其係可於量測受測者的心律變異度時,不易受測者讓感到緊張或者不耐煩,如此可真實量測受測者之實際的心率變異,以取得自然心律及心律變異,而非量測到受情緒緊張影響心跳之心律變異,以解決上述之問題。Therefore, the present invention provides a measuring device for heart rate variability, which is capable of measuring the heart rate variability of a subject, and is not easy for the subject to feel nervous or impatient, so that the actual measurement of the subject can be truly measured. Heart rate variability, in order to achieve natural heart rhythm and heart rhythm variation, rather than measuring the heart rate variability affected by emotional stress, to solve the above problems.
本發明之目的之一,在於提供一種心律變異度之量測裝置,其係藉由一光體積描記訊號量測模組與一心電圖訊號量測模組量同時量測人體不同之生理訊號,因增加生理訊號量測之便利性,並於一耳機本體設置光體積描記訊號量測模組,讓光體積描記訊號量測模組與心電圖訊號量測模組量測受測者之生理訊號時,藉由耳機本體撥放聲音訊號以避免受測者將注意力集中在光體積描記訊號量測模組或心電圖訊號量測模組上,以消除受測者的緊張或者不耐煩,如此可真實量測受測者之實際的心律變異。One of the objects of the present invention is to provide a measuring device for heart rate variability, which simultaneously measures different physiological signals of a human body by using a photoplethysmographic signal measuring module and an electrocardiogram signal measuring module. Increasing the convenience of physiological signal measurement, and setting a photoplethysmography signal measurement module on a headphone body, and letting the photoplethysmography signal measurement module and the electrocardiogram signal measurement module measure the physiological signals of the subject, The sound signal is played by the earphone body to prevent the subject from focusing on the light plethysmography signal measurement module or the electrocardiogram signal measurement module, so as to eliminate the tension or impatience of the subject, so that the true amount can be Measure the actual heart rhythm variation of the subject.
本發明之心律變異度之量測裝置包含一耳機本體、一光體積描記訊號量測模組、一光體積描記訊號處理模組、一心電圖訊號量測模組、一心電圖訊號處理模組與一控制處理單元;耳機本體置入於一人體之一人耳;光體積描記訊號量測模組設於耳機本體之一側,光體積描記訊號量測模組經由該人耳量測人體之生理狀態而產生一第一生理訊號;光體積描記訊號處理模組發出一聲音訊號至該機本體,光體積描記訊號處理模組接收第一生理訊號並依據該第一生理訊號而產生一第一量測訊號;心電圖訊號量測模組量測人體之生理狀態而產生一第二生理訊號;心電圖訊號處理模組接收第二生理訊號並依據第二生理訊號而產生一第二量測訊號;控制處理單元發出一聲音訊號,控制處理單元接收第一量測訊號並對應產生一第一波形圖,且控制處理單元接收第二量測訊號並對應產生一第二波形圖。藉由耳機本體撥放聲音訊號以避免受測者將注意力集中在光體積描記訊號量測模組或心電圖訊號量測模組上,以消除受測者的緊張或者不耐煩,如此可真實量測受測者之實際的心律變異。The measuring device for cardiac rhythm variability of the present invention comprises a headphone body, a photoplethysmographic signal measuring module, a photoplethysmographic signal processing module, an electrocardiogram signal measuring module, an electrocardiogram signal processing module and a a control processing unit; the earphone body is placed in a human ear; the photoplethysmographic signal measurement module is disposed on one side of the earphone body, and the photoplethysmographic signal measurement module measures the physiological state of the human body through the human ear. Generating a first physiological signal; the photoplethysmographic signal processing module sends an audio signal to the body of the machine, and the photoplethysmographic signal processing module receives the first physiological signal and generates a first measurement signal according to the first physiological signal. The ECG signal measurement module measures the physiological state of the human body to generate a second physiological signal; the ECG signal processing module receives the second physiological signal and generates a second measurement signal according to the second physiological signal; the control processing unit issues An audio signal, the control processing unit receives the first measurement signal and correspondingly generates a first waveform, and the control processing unit receives the second measurement A second number and generating a corresponding waveform diagram. The sound signal is played by the earphone body to prevent the subject from focusing on the light plethysmography signal measurement module or the electrocardiogram signal measurement module, so as to eliminate the tension or impatience of the subject, so that the true amount can be Measure the actual heart rhythm variation of the subject.
茲為使 貴審查委員對本發明之結構特徵及所達成之功效有更進一步之瞭解與認識,謹佐以較佳之實施例及配合詳細之說明,說明如後:In order to provide a better understanding and understanding of the structural features and efficacies of the present invention, the preferred embodiments and detailed descriptions are provided as follows:
請參閱第一圖,其係為本發明較佳實施例之方塊圖,如圖所示;本發明之心律變異度之量測裝置包含一耳機本體10、一光體積描記訊號量測模組20、一光體積描記訊號處理模組30、一心電圖訊號量測模組40、一心電圖訊號處理模組50與一控制處理單元60;耳機本體10置入於一人體之一人耳70(請參閱第二圖);光體積描記訊號量測模組20設於耳機本體10之一側,光體積描記訊號量測模組20經由該入耳70量測人體之生理狀態而產生一第一生理訊號;光體積描記訊號處理模組30發出一聲音訊號至該機本體,光體積描記訊號處理模組30接收第一生理訊號並依據該第一生理訊號而產生一第一量測訊號;心電圖訊號量測模組40量測人體之生理狀態而產生一第二生理訊號;心電圖訊號處理模組50接收第二生理訊號並依據第二生理訊號而產生一第二量測訊號;控制處理單元60發出一聲音訊號,控制處理單元60接收第一量測訊號並對應產生一第一波形圖,如心跳的弦波,且控制處理單元60接收第二量測訊號並對應產生一第二波形圖,如一心電圖。藉由耳機本體10撥放聲音訊號以避免受測者將注意力集中在光體積描記訊號量測模組20或心電圖訊號量測模組40上,以消除受測者的緊張或者不耐煩,如此可真實量測受測者之實際的心律變異。Referring to the first drawing, which is a block diagram of a preferred embodiment of the present invention, as shown in the figure, the measuring device for cardiac rhythm variability of the present invention comprises a headphone body 10 and a photoplethysmographic signal measuring module 20 a photoplethysmographic signal processing module 30, an electrocardiogram signal measuring module 40, an electrocardiogram signal processing module 50 and a control processing unit 60; the earphone body 10 is placed in a human ear 70 (see the The light plethysmography signal measurement module 20 is disposed on one side of the earphone body 10, and the photoplethysmography signal measurement module 20 measures a physiological state of the human body through the ear 70 to generate a first physiological signal; The plethysmographic signal processing module 30 sends an audio signal to the main body of the machine. The photoplethysmography signal processing module 30 receives the first physiological signal and generates a first measurement signal according to the first physiological signal; the electrocardiogram signal measurement mode The group 40 measures the physiological state of the human body to generate a second physiological signal; the ECG signal processing module 50 receives the second physiological signal and generates a second measurement signal according to the second physiological signal; the control processing unit 60 sends An audio signal, the control processing unit 60 receives the first measurement signal and correspondingly generates a first waveform, such as a heartbeat sine wave, and the control processing unit 60 receives the second measurement signal and correspondingly generates a second waveform, such as ECG. The audio signal is played by the earphone body 10 to prevent the subject from focusing on the photoplethysmography signal measurement module 20 or the electrocardiogram signal measurement module 40, so as to eliminate the tension or impatience of the subject. The actual heart rhythm variation of the subject can be measured realistically.
本發明更包含一第一儲存單元80,第一儲存單元80耦接控制處理單元60,控制處理單元60儲存第一量測訊號與第二量測訊號至第一儲存單元80。第一儲存單元80為一CF卡(Compact Flash Card)。CF卡具有容量大、體積小、高性能、攜帶方便等優點,而且讀寫速度快,可與多種電腦作業系統平台相容,因此在數據採集系統中的數據紀錄或與PC之間的數據存取多採用CF卡。CF卡內部包含了控制器、Flash Memory陣列和讀寫緩衝區。內置的智慧控制器,使周邊電路設計大大簡化,而且完全符合PC記憶體卡的國際聯合會PCMCIA(Personal Computer Memory Card International Association)和ATA(Advanced Technology Attachment)介面規範。CF卡的緩衝區結構,使得外部設備與CF卡通信的同時,CF卡內的控制器可以對Flash進行讀寫。這種設計可以增加CF卡數據讀寫的可靠性,同時提高數據傳輸速率。CF卡支援多種介面模式,有符合PCMCIA規範的Memory Mapped模式、I/O Card模式和符合ATA規範的True IDE模式。上電時,OE為低電位時,CF卡進入True IDE模式,此時OE也叫ATA SEL;上電時,OE為高電位時,CF卡進入PCMCIA模式,即Memory Mapped模式或I/O Card模式,此時可通過修改配置選項暫存器進入相對應的模式。The present invention further includes a first storage unit 80. The first storage unit 80 is coupled to the control processing unit 60. The control processing unit 60 stores the first measurement signal and the second measurement signal to the first storage unit 80. The first storage unit 80 is a CompactFlash Card. The CF card has the advantages of large capacity, small size, high performance, convenient carrying, etc., and has fast reading and writing speed, and is compatible with various computer operating system platforms, so data records in the data acquisition system or data storage with the PC. Take more CF cards. The CF card contains the controller, Flash Memory array, and read and write buffers. The built-in smart controller greatly simplifies the peripheral circuit design and is fully compliant with the PCMCIA (Personal Computer Memory Card International Association) and ATA (Advanced Technology Attachment) interface specifications of the PC memory card. The buffer structure of the CF card enables the external device to communicate with the CF card, and the controller in the CF card can read and write the Flash. This design can increase the reliability of CF card data reading and writing, while increasing the data transmission rate. The CF card supports multiple interface modes, including Memory Mapped mode conforming to the PCMCIA specification, I/O Card mode, and True IDE mode conforming to the ATA specification. On power-up, when OE is low, the CF card enters True IDE mode. At this time, OE is also called ATA SEL. When OE is high, the CF card enters PCMCIA mode, ie Memory Mapped mode or I/O Card. Mode, you can enter the corresponding mode by modifying the configuration option register.
本發明更包含一液晶顯示器90,液晶顯示器90與控制處理單元60耦接,控制處理單元60傳送第一波形圖與第二波形圖至液晶顯示器90而顯示。本發明之液晶顯示器90使用一薄膜電晶體液晶顯示器90(TFT-LCD,Thin-Film Transistor Liquid-Crystal Display)。TFT-LCD面板可視為兩片玻璃基板中間夾著一層液晶,上層的玻璃基板是與彩色濾光片(Color Filter)、而下層的玻璃則有電晶體鑲嵌於上。當電流通過電晶體產生電場變化,造成液晶分子偏轉,藉以改變光線的偏極性,再利用偏光片決定畫素(Pixel)的明暗狀態。此外,上層玻璃因與彩色濾光片貼合,形成每個畫素(Pixel)各包含紅藍綠三顏色,這些發出紅藍綠色彩的畫素便構成了面板上的影像畫面。The present invention further includes a liquid crystal display 90 coupled to the control processing unit 60. The control processing unit 60 transmits the first waveform diagram and the second waveform diagram to the liquid crystal display 90 for display. The liquid crystal display 90 of the present invention uses a thin film transistor liquid crystal display 90 (TFT-LCD, Thin-Film Transistor Liquid-Crystal Display). The TFT-LCD panel can be seen as a layer of liquid crystal sandwiched between two glass substrates, an upper glass substrate and a color filter, and a lower glass with a transistor mounted thereon. When a current is passed through the transistor to generate an electric field change, causing the liquid crystal molecules to deflect, thereby changing the polarity of the light, and then using a polarizer to determine the brightness of the pixel (Pixel). In addition, the upper glass is bonded to the color filter, and each pixel (Pixel) is composed of three colors of red, blue and green. These red, blue and green color pixels form an image on the panel.
本發明更包含至少一第二儲存單元100,第二儲存單元100儲存一多媒體資料,多媒體資料例如MP3,控制處理單元60讀取多媒體資料並轉換而發出聲音訊號。而且,本發明更包含一USB傳輸模組110,控制處理單元60傳送第一量測訊號與第二量測訊號至USB傳輸模組110,以傳送至一電腦。而所得之時序脈搏資料及分析後之心率變異資料可經由Borland C++Builder編輯視窗化軟體使用者介面程式,顯示系統平台的分析結果及儲存。而且USB傳輸模組110也能讓資料在電腦和第一儲存單元80之間傳輸。The present invention further includes at least one second storage unit 100. The second storage unit 100 stores a multimedia material, such as an MP3, and the control processing unit 60 reads the multimedia data and converts it to emit an audio signal. Moreover, the present invention further includes a USB transmission module 110. The control processing unit 60 transmits the first measurement signal and the second measurement signal to the USB transmission module 110 for transmission to a computer. The obtained time-series pulse data and the analyzed heart rate variability data can be edited by Borland C++Builder to edit the windowed software user interface program to display the analysis results and storage of the system platform. Moreover, the USB transmission module 110 can also transfer data between the computer and the first storage unit 80.
控制處理單元60主要用在數位媒體播放器,控制處理單元60之晶片可以做MP3的編碼和解碼或是其他形式音訊(例如:WMA)的壓縮和解壓縮。在開始播放音樂之後,51端每隔130ms就會把第二儲存單元100內所儲存的音訊資料播放出來。並且在處理第一量測訊號與第二量測訊號時,不會造成音樂的中斷。The control processing unit 60 is mainly used in a digital media player, and the chip of the control processing unit 60 can perform encoding and decoding of MP3 or compression and decompression of other forms of audio (for example, WMA). After starting to play the music, the 51th end will play the audio data stored in the second storage unit 100 every 130ms. Moreover, when the first measurement signal and the second measurement signal are processed, no interruption of music is caused.
請參閱第二圖,其係為本發明較佳實施例之光體積描記訊號量測模組之結構示意圖與耳機本體設置於人耳之示意圖,如圖所示;本發明之光體積描記訊號量測模組20包含一光源22與一光感測器24,光源22設於耳機本體10之一側;光源22設於耳機本體10之一側,光源22照射人耳70之皮膚並產生一反射光;光感測器24設於耳機本體10並位於光源22之同側,光感測器24接收反射光,並依據反射光產生第一生理訊號,且傳送第一生理訊號至光體積描記訊號處理模組30。Please refer to the second figure, which is a schematic structural diagram of a photoplethysmography signal measuring module according to a preferred embodiment of the present invention, and a schematic diagram of the earphone body disposed on the human ear, as shown in the figure; the optical plethysmograph signal amount of the present invention The measuring module 20 includes a light source 22 and a light sensor 24. The light source 22 is disposed on one side of the earphone body 10; the light source 22 is disposed on one side of the earphone body 10, and the light source 22 illuminates the skin of the human ear 70 and generates a reflection. The light sensor 24 is disposed on the earphone body 10 and located on the same side of the light source 22. The light sensor 24 receives the reflected light, generates a first physiological signal according to the reflected light, and transmits the first physiological signal to the photoplethysmographic signal. Processing module 30.
本發明之耳機本體10包含一置入部12與一容置部14,置入部12置入於人耳70,耳機本體10設有一揚聲器16,揚聲器16則設於置入部12內,容置部14設於置入部12之一側,光源22與光感測器24設於容置部14。當耳機本體10撥放音樂供受測者聆聽時,藉由設置於耳機本體10上之光源22與光感測器24以量測受測者的心律變異度,如此避免受測者將注意力集中在心律變異度的量測裝置上,以消除受測者的緊張或者不耐煩,以真實量測受測者之實際的心律變異。The earphone body 10 of the present invention includes an insertion portion 12 and a receiving portion 14 . The insertion portion 12 is disposed in the human ear 70 . The earphone body 10 is provided with a speaker 16 , and the speaker 16 is disposed in the insertion portion 12 . The receiving portion 14 is disposed on one side of the insertion portion 12 , and the light source 22 and the photo sensor 24 are disposed on the receiving portion 14 . When the earphone body 10 plays music for the subject to listen to, the light source 22 and the light sensor 24 disposed on the earphone body 10 are used to measure the heart rate variability of the subject, thus avoiding the subject's attention. Focus on the measurement device of the heart rate variability to eliminate the tension or impatience of the subject, and actually measure the actual heart rhythm variation of the subject.
本發明之是採用光體積變化描記圖(Potoplethy-smography,PPG)來擷取第一生理訊號,這種方法需要以一紅光LED之光源22和光接收電晶體之光感測器24作為PPG的探頭,光源22包含一紅光,光源22可為一紅光LED,紅光之波長為640nm;光感測器24包含一光接收電晶體。由於光接收電晶體之體積較小,故將光感測器24與光源22設置於耳機本體10,使用者不易察覺PPG的探頭位置,以讓受測者邊聽音樂時邊量測訊號時,藉由這種此方式可以在受測者在量測過程中,消除受測者緊張的感覺,以取得使用者長時間的自然心率變異資訊,以達到較佳的量測效果。In the present invention, a first physiological signal is captured by using a Potoplethy-smography (PPG), which requires a light source 22 of a red LED and a photosensor 24 of the light receiving transistor as a PPG. The light source 22 includes a red light source, the light source 22 can be a red light LED, and the red light has a wavelength of 640 nm. The light sensor 24 includes a light receiving transistor. Since the light receiving transistor has a small volume, the photo sensor 24 and the light source 22 are disposed on the earphone body 10, and the user does not easily perceive the probe position of the PPG, so that the subject measures the signal while listening to music. In this way, the subject can be eliminated in the measurement process, and the user's natural heart rate variability information can be obtained for a long time to achieve a better measurement effect.
請一並參閱第三圖,其係為本發明較佳實施例之光體積變化量測示意圖;如圖所示,光體積變化描記圖是基於選定皮膚區塊,以近紅外光源22打入皮膚內而量測光的特性。當光在生物組織中行進時,會被不同吸收物質所吸收,例如膚色、骨骼、動脈及靜脈血液。此外動脈血管在心臟收縮期間比在舒張期間包含更多血液,動脈管徑也因為壓力的增加而變大,這影響只發生在動脈及小動脈,並不會發生在靜脈。當動脈在心臟收縮期間,光被吸收度增加,主要是大量吸收光的物質增加(血紅素)以及光在動脈中行進的距離增加,對於整體吸收度而言,就猶如一交流成分,而此種交流成分可幫助我們區別由靜脈血液、動脈血液中不變的數量以及其他像膚色等沒有脈動成分(直流成分)所造成之光吸收度與由動脈血管中脈動成分(交流成分)所造成之光吸收度的差異。此交流成分不會超過直流程份的1%-2%。因此接收這種隨時間、組織變化之光訊號波形稱作光體積變化描記圖。故本發明利用光源22穿射人耳70之皮膚之一表皮層72,穿過表皮層72之光線經由表皮層72下方之一真皮層74反射出反射光。Please refer to the third figure, which is a schematic diagram of the measurement of the light volume change according to the preferred embodiment of the present invention; as shown in the figure, the light volume change trace is based on the selected skin block and is driven into the skin by the near-infrared light source 22. And the characteristics of the measurement light. As light travels through biological tissues, it is absorbed by different absorbent substances such as skin color, bones, arteries, and venous blood. In addition, arterial blood vessels contain more blood during systole than during diastole, and the arterial diameter also becomes larger due to increased pressure. This effect only occurs in arteries and small arteries and does not occur in veins. When the artery contracts during systole, the absorbance of light increases, mainly because of the increased amount of light-absorbing substances (heme) and the distance traveled by light in the artery. For the overall absorbance, it is like an AC component. The AC component helps us to distinguish between the amount of light in the venous blood, arterial blood, and other non-pulsating components (DC components) such as skin color, and the pulsating component (AC component) in the arteries. The difference in light absorption. This communication component will not exceed 1%-2% of the straight process. Therefore, receiving such a light signal waveform with time and tissue changes is called a light volume change trace. Therefore, the present invention utilizes the light source 22 to penetrate one of the skin layers 72 of the skin of the human ear 70, and the light passing through the skin layer 72 reflects the reflected light through one of the dermis layers 74 below the skin layer 72.
綜上所述,本發明係有關於一種心律變異度之量測裝置包含一耳機本體;一光體積描記訊號量測模組設於耳機本體之一側,光體積描記訊號量測模組經由人耳以量測人體之生理狀態而產生一第一生理訊號;一心電圖訊號量測模組量測人體之生理狀態而產生一第二生理訊號;一控制處理單元傳輸聲音訊號至耳機本體。藉由耳機本體撥放聲音訊號以避免受測者將注意力集中在光體積描記訊號量測模組或心電圖訊號量測模組上,以消除受測者的緊張或者不耐煩,如此可真實量測受測者之實際的心律變異。In summary, the present invention relates to a measuring device for heart rate variability comprising a headphone body; a photoplethysmographic signal measuring module is disposed on one side of the earphone body, and the photoplethysmography signal measuring module is passed through a person The ear generates a first physiological signal by measuring the physiological state of the human body; an ECG signal measuring module measures the physiological state of the human body to generate a second physiological signal; and a control processing unit transmits the sound signal to the earphone body. The sound signal is played by the earphone body to prevent the subject from focusing on the light plethysmography signal measurement module or the electrocardiogram signal measurement module, so as to eliminate the tension or impatience of the subject, so that the true amount can be Measure the actual heart rhythm variation of the subject.
故本發明係實為一具有新穎性、進步性及可供產業利用者,應符合我國專利法所規定之專利申請要件無疑,爰依法提出發明專利申請,祈 鈞局早日賜准專利,至感為禱。Therefore, the present invention is a novelty, progressive and available for industrial use. It should be in accordance with the patent application requirements stipulated in the Patent Law of China, and the invention patent application is filed according to law, and the prayer bureau will grant the patent as soon as possible. For prayer.
惟以上所述者,僅為本發明之一較佳實施例而已,並非用來限定本發明實施之範圍,舉凡依本發明申請專利範圍所述之形狀、構造、特徵及精神所為之均等變化與修飾,均應包括於本發明之申請專利範圍內。However, the above description is only a preferred embodiment of the present invention, and is not intended to limit the scope of the present invention, and the shapes, structures, features, and spirits described in the claims are equivalently changed. Modifications are intended to be included in the scope of the patent application of the present invention.
10...耳機本體10. . . Headset body
12...置入部12. . . Placement department
14...容置部14. . . Housing
16...揚聲器16. . . speaker
20...光體積描記訊號量測模組20. . . Light plethysmography signal measurement module
22...光源twenty two. . . light source
24...光感測器twenty four. . . Light sensor
30...光體積描記訊號處理模組30. . . Light plethysmography signal processing module
40...心電圖訊號量測模組40. . . ECG signal measurement module
50...心電圖訊號處理模組50. . . ECG signal processing module
60...控制處理單元60. . . Control processing unit
70...人耳70. . . Human ear
72...表皮層72. . . Epidermis
74...真皮層74. . . Dermis
80...第一儲存單元80. . . First storage unit
90...液晶顯示器90. . . LCD Monitor
100...第二儲存單元100. . . Second storage unit
110...USB傳輸模組110. . . USB transmission module
第一圖其係為本發明較佳實施例之方塊圖;The first figure is a block diagram of a preferred embodiment of the present invention;
第二圖為本發明較佳實施例之心律變異度之量測耳機的結構示意圖;2 is a schematic structural view of a measuring head of a heart rate variability according to a preferred embodiment of the present invention;
第三圖為本發明較佳實施例之與耳機設置於人耳之示意圖;以及The third figure is a schematic diagram of a headset disposed on a human ear according to a preferred embodiment of the present invention;
第四圖為本發明較佳實施例之光體積變化量測示意圖。The fourth figure is a schematic diagram of light volume change measurement according to a preferred embodiment of the present invention.
10...耳機本體10. . . Headset body
30...光體積描記訊號處理模組30. . . Light plethysmography signal processing module
40...心電圖訊號量測模組40. . . ECG signal measurement module
50...心電圖訊號處理模組50. . . ECG signal processing module
60...控制處理單元60. . . Control processing unit
80...第一儲存單元80. . . First storage unit
90...液晶顯示器90. . . LCD Monitor
100...第二儲存單元100. . . Second storage unit
110...USB傳輸模組110. . . USB transmission module
Claims (15)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW098114098A TWI449514B (en) | 2009-04-28 | 2009-04-28 | Measurement of arrhythmia |
US12/726,820 US20100274109A1 (en) | 2009-04-28 | 2010-03-18 | Measurement apparatus for heart rate variability |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW098114098A TWI449514B (en) | 2009-04-28 | 2009-04-28 | Measurement of arrhythmia |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201038249A TW201038249A (en) | 2010-11-01 |
TWI449514B true TWI449514B (en) | 2014-08-21 |
Family
ID=42992720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW098114098A TWI449514B (en) | 2009-04-28 | 2009-04-28 | Measurement of arrhythmia |
Country Status (2)
Country | Link |
---|---|
US (1) | US20100274109A1 (en) |
TW (1) | TWI449514B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI547261B (en) * | 2015-01-29 | 2016-09-01 | 原相科技股份有限公司 | Array physiological detection system and operating method thereof |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8652040B2 (en) | 2006-12-19 | 2014-02-18 | Valencell, Inc. | Telemetric apparatus for health and environmental monitoring |
US8157730B2 (en) | 2006-12-19 | 2012-04-17 | Valencell, Inc. | Physiological and environmental monitoring systems and methods |
US8251903B2 (en) | 2007-10-25 | 2012-08-28 | Valencell, Inc. | Noninvasive physiological analysis using excitation-sensor modules and related devices and methods |
US8588880B2 (en) | 2009-02-16 | 2013-11-19 | Masimo Corporation | Ear sensor |
EP3127476A1 (en) | 2009-02-25 | 2017-02-08 | Valencell, Inc. | Light-guiding devices and monitoring devices incorporating same |
US9750462B2 (en) | 2009-02-25 | 2017-09-05 | Valencell, Inc. | Monitoring apparatus and methods for measuring physiological and/or environmental conditions |
US8788002B2 (en) | 2009-02-25 | 2014-07-22 | Valencell, Inc. | Light-guiding devices and monitoring devices incorporating same |
US8888701B2 (en) | 2011-01-27 | 2014-11-18 | Valencell, Inc. | Apparatus and methods for monitoring physiological data during environmental interference |
US9427191B2 (en) | 2011-07-25 | 2016-08-30 | Valencell, Inc. | Apparatus and methods for estimating time-state physiological parameters |
WO2013019494A2 (en) | 2011-08-02 | 2013-02-07 | Valencell, Inc. | Systems and methods for variable filter adjustment by heart rate metric feedback |
CN104168828A (en) | 2012-01-16 | 2014-11-26 | 瓦伦赛尔公司 | Physiological metric estimation rise and fall limiting |
WO2013109390A1 (en) * | 2012-01-16 | 2013-07-25 | Valencell, Inc. | Reduction of physiological metric error due to inertial cadence |
FI124563B (en) | 2012-08-28 | 2014-10-15 | Mega Elektroniikka Oy | Arrangement for measuring a biosignal |
WO2014109982A2 (en) | 2013-01-09 | 2014-07-17 | Valencell Inc. | Cadence detection based on inertial harmonics |
CN105050494B (en) | 2013-01-28 | 2018-06-12 | 瓦伦赛尔公司 | Physiological monitoring device with the sensing element disengaged with body kinematics |
US20140275888A1 (en) * | 2013-03-15 | 2014-09-18 | Venture Gain LLC | Wearable Wireless Multisensor Health Monitor with Head Photoplethysmograph |
EP3146896B1 (en) | 2014-02-28 | 2020-04-01 | Valencell, Inc. | Method and apparatus for generating assessments using physical activity and biometric parameters |
US9538921B2 (en) | 2014-07-30 | 2017-01-10 | Valencell, Inc. | Physiological monitoring devices with adjustable signal analysis and interrogation power and monitoring methods using same |
US10536768B2 (en) | 2014-08-06 | 2020-01-14 | Valencell, Inc. | Optical physiological sensor modules with reduced signal noise |
US9794653B2 (en) * | 2014-09-27 | 2017-10-17 | Valencell, Inc. | Methods and apparatus for improving signal quality in wearable biometric monitoring devices |
ITMI20140312U1 (en) * | 2014-10-10 | 2016-04-10 | Microbiomed S R L | DEVICE FOR THE STUDY AND DIAGNOSIS OF NEURODEGENERATIVE DISORDERS |
US10945618B2 (en) | 2015-10-23 | 2021-03-16 | Valencell, Inc. | Physiological monitoring devices and methods for noise reduction in physiological signals based on subject activity type |
WO2017070463A1 (en) | 2015-10-23 | 2017-04-27 | Valencell, Inc. | Physiological monitoring devices and methods that identify subject activity type |
WO2018009736A1 (en) | 2016-07-08 | 2018-01-11 | Valencell, Inc. | Motion-dependent averaging for physiological metric estimating systems and methods |
CN115251876A (en) * | 2018-06-04 | 2022-11-01 | 原相科技股份有限公司 | Physiological detection device |
CN113040778B (en) * | 2019-12-26 | 2022-07-29 | 华为技术有限公司 | Diagnostic report generation method and device, terminal equipment and readable storage medium |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6662032B1 (en) * | 1999-07-06 | 2003-12-09 | Intercure Ltd. | Interventive-diagnostic device |
TWM344138U (en) * | 2008-04-25 | 2008-11-11 | jin-ye Hong | Behind-the-ear low frequency wireless heartbeat detector |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5372134A (en) * | 1993-05-24 | 1994-12-13 | Richardson; Joseph W. | Aviation hypoxia monitor |
JP3853053B2 (en) * | 1997-12-17 | 2006-12-06 | 松下電器産業株式会社 | Biological information measuring device |
US6080110A (en) * | 1999-04-19 | 2000-06-27 | Tel, Inc. | Heartbeat monitor for wearing during exercise |
US6622095B2 (en) * | 1999-11-30 | 2003-09-16 | Nihon Kohden Corporation | Apparatus for determining concentrations of hemoglobins |
US6808473B2 (en) * | 2001-04-19 | 2004-10-26 | Omron Corporation | Exercise promotion device, and exercise promotion method employing the same |
WO2006033104A1 (en) * | 2004-09-22 | 2006-03-30 | Shalon Ventures Research, Llc | Systems and methods for monitoring and modifying behavior |
JP2009502298A (en) * | 2005-07-28 | 2009-01-29 | ヒッポック リミティド | Ear-mounted biosensor |
KR100882440B1 (en) * | 2006-11-27 | 2009-02-06 | 삼성전자주식회사 | Biological signal detection device and method |
US20080132798A1 (en) * | 2006-11-30 | 2008-06-05 | Motorola, Inc | Wireless headsets and wireless communication networks for heart rate monitoring |
US20090105556A1 (en) * | 2007-09-28 | 2009-04-23 | Tiax Llc | Measurement of physiological signals |
EP3127476A1 (en) * | 2009-02-25 | 2017-02-08 | Valencell, Inc. | Light-guiding devices and monitoring devices incorporating same |
US20100246651A1 (en) * | 2009-03-31 | 2010-09-30 | Qualcomm Incorporated | Packet loss mitigation in transmission of biomedical signals for healthcare and fitness applications |
TW201036592A (en) * | 2009-04-15 | 2010-10-16 | Univ Nat Yang Ming | A method and system of auditory evoked heart rate variability analysis |
US20100331631A1 (en) * | 2009-06-30 | 2010-12-30 | Nellcor Puritan Bennett Llc | Oxygen saturation ear sensor design that optimizes both attachment method and signal quality |
US8858430B2 (en) * | 2010-03-09 | 2014-10-14 | Zipline Health, Inc. | Ear ailment diagnostic device and method |
-
2009
- 2009-04-28 TW TW098114098A patent/TWI449514B/en not_active IP Right Cessation
-
2010
- 2010-03-18 US US12/726,820 patent/US20100274109A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6662032B1 (en) * | 1999-07-06 | 2003-12-09 | Intercure Ltd. | Interventive-diagnostic device |
TWM344138U (en) * | 2008-04-25 | 2008-11-11 | jin-ye Hong | Behind-the-ear low frequency wireless heartbeat detector |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI547261B (en) * | 2015-01-29 | 2016-09-01 | 原相科技股份有限公司 | Array physiological detection system and operating method thereof |
Also Published As
Publication number | Publication date |
---|---|
TW201038249A (en) | 2010-11-01 |
US20100274109A1 (en) | 2010-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI449514B (en) | Measurement of arrhythmia | |
TWI439255B (en) | Measurement of arrhythmia | |
TWI439254B (en) | Heart rate variability measurement headphones | |
Kyriacou et al. | Photoplethysmography: technology, signal analysis and applications | |
Cui et al. | In vivo reflectance of blood and tissue as a function of light wavelength | |
Peper et al. | Is there more to blood volume pulse than heart rate variability, respiratory sinus arrhythmia, and cardiorespiratory synchrony? | |
Scardulla et al. | Photoplethysmograhic sensors, potential and limitations: Is it time for regulation? A comprehensive review | |
Marcinkevics et al. | Imaging photoplethysmography for clinical assessment of cutaneous microcirculation at two different depths | |
US20060063995A1 (en) | Optical measurement of tissue blood flow, hemodynamics and oxygenation | |
US20230225623A1 (en) | Methods And Systems For Non-Invasive Cuff-Less Blood Pressure Monitoring | |
CN110464344A (en) | The method for collecting the device of eeg signal acquisition and music and its playing music | |
WO2015187732A1 (en) | Optical sensor for health monitoring | |
Zhou et al. | Study of a ring-type surgical pleth index monitoring system based on flexible PPG sensor | |
Blazek et al. | Customized optoelectronic in-ear sensor approaches for unobtrusive continuous monitoring of cardiorespiratory vital signs | |
US20070239039A1 (en) | Method and apparatus for measuring blood pressures by using blood oxygen concentration and electrocardiography | |
US10123738B1 (en) | Methods and apparatus for skin color patient monitoring | |
WO2022182956A1 (en) | Remote monitoring of oxygenation status and blood pulsation within skin tissue | |
TW201216922A (en) | capable of eliminating the use of a digital-analog converter unit to reduce the size of the pulsation sensor module | |
Campbell | Development of non-invasive, optical methods for central cardiovascular and blood chemistry monitoring. | |
Laulkar et al. | Applications of finger photoplethysmography | |
TWI409050B (en) | Pulse sensing device | |
CN112806992B (en) | Tissue oxygen saturation monitoring system and method of self-adaptive spatial resolution spectrum | |
Khong et al. | The evolution of heart beat rate measurement techniques from contact based photoplethysmography to non-contact based photoplethysmography imaging | |
Pamuk et al. | Detection of Heart Rate Variability from Photoplethysmography (PPG) Signals Obtained by Raspberry Pi Microcomputer | |
Feukeu et al. | Photoplethysmography: Light Emitter Diode Wavelength Derivation from the Absorption Spectra of Haemoglobin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |